CytoMed Therapeutics Quote - GDTC

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.81

Bid

2.34

Ask

2.81

Volume

0.00 Day's Range 0.00

1.20 52 Week Range 3.98

Market Cap

32.427M

Previous Close

2.81

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

229,321

Shares Outstanding

11,540,000

Dividend Yield

PE Ratio

-7.85

Earnings Per Share (EPS)

-0.36

Revenue

518k

Net Profit

-4.13M

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cytomed.sg.

Headquarters

Singapore, Sgp

Founded

CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was US$2.81. Over the last year, CytoMed Therapeutics shares have traded in a share price range of US$ 1.20 to US$ 3.98.

CytoMed Therapeutics currently has 11,540,000 shares outstanding. The market capitalization of CytoMed Therapeutics is US$32.43 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -7.85.

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders

SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial

SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.13	4.85074626866	2.68	2.81	2.6	9159	2.77410543	CS
4	0.05	1.8115942029	2.76	2.94	2.46	14447	2.7608958	CS
12	-0.08	-2.76816608997	2.89	3.98	2.12	229321	3.32808779	CS
26	1.31	87.3333333333	1.5	3.98	1.2	110447	3.26447267	CS
52	0.54	23.7885462555	2.27	3.98	1.2	72006	3.00020732	CS
156	-1.19	-29.75	4	9.25	1.2	115094	4.27463454	CS
260	-1.19	-29.75	4	9.25	1.2	115094	4.27463454	CS

GDTC - Frequently Asked Questions (FAQ)

What is the current CytoMed Therapeutics share price?

The current share price of CytoMed Therapeutics is US$ 2.81

How many CytoMed Therapeutics shares are in issue?

CytoMed Therapeutics has 11,540,000 shares in issue

What is the market cap of CytoMed Therapeutics?

The market capitalisation of CytoMed Therapeutics is USD 32.43M

What is the 1 year trading range for CytoMed Therapeutics share price?

CytoMed Therapeutics has traded in the range of US$ 1.20 to US$ 3.98 during the past year

What is the PE ratio of CytoMed Therapeutics?

The price to earnings ratio of CytoMed Therapeutics is -7.85

What is the cash to sales ratio of CytoMed Therapeutics?

The cash to sales ratio of CytoMed Therapeutics is 62.58

What is the reporting currency for CytoMed Therapeutics?

CytoMed Therapeutics reports financial results in SGD

What is the latest annual turnover for CytoMed Therapeutics?

The latest annual turnover of CytoMed Therapeutics is SGD 518k

What is the latest annual profit for CytoMed Therapeutics?

The latest annual profit of CytoMed Therapeutics is SGD -4.13M

What is the registered address of CytoMed Therapeutics?

The registered address for CytoMed Therapeutics is #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, SINGAPORE, 149544

What is the CytoMed Therapeutics website address?

The website address for CytoMed Therapeutics is www.cytomed.sg.

Which industry sector does CytoMed Therapeutics operate in?

CytoMed Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PTIXProtagenic Therapeutics Inc	US$ 0.4898 (77.27%)	10.74M
BTOGBit Origin Ltd	US$ 0.4978 (55.90%)	19.16M
SVRASavara Inc	US$ 3.00 (29.31%)	67
CDTConduit Pharmaceuticals Inc	US$ 1.50 (29.31%)	2.66M
GCLGCL Global Holdings Ltd	US$ 2.59 (28.22%)	440
SYRESpyre Therapeutics Inc	US$ 11.00 (-38.68%)	4
SPGCSacks Parente Golf Inc	US$ 0.11925 (-37.24%)	4.43M
OPCHOption Care Health Inc	US$ 22.01 (-35.19%)	16
EOLSEvolus Inc	US$ 9.32 (-35.01%)	8
MIRMMirum Pharmaceuticals Inc	US$ 32.01 (-30.40%)	38
BTOGBit Origin Ltd	US$ 0.4964 (55.47%)	19.16M
PTIXProtagenic Therapeutics Inc	US$ 0.4898 (77.27%)	10.74M
SPGCSacks Parente Golf Inc	US$ 0.11925 (-37.24%)	4.43M
CDTConduit Pharmaceuticals Inc	US$ 1.50 (29.31%)	2.66M
SPPLSIMPPLE Ltd	US$ 0.49 (17.93%)	2.23M